Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-alpha-V integrin antibody for the treatment of prostate cancer

Anti-alpha-V integrin antibody for the treatment of prostate cancer

US Patent 9555110 · Granted Jan 31, 2017

Estimated economic value: $47,481,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic dis2022
Super resolution for magneto-optical microscopy2022
Fork leg for rotating a wheel of a motor vehicle2022
Semiconductor device having an internal-field-guarded active region2019
Genomic markers for prediction of long-term response to 2 years of growth hormon2015
Genomic markers for prediction of long-term response to growth hormone (GH) ther2015
Pharmaceutical composition comprising a bispecific antibody for EpCAM2014
Pharmaceutical composition comprising a bispecific antibody for EpCAM2011
Magneto-optic biosensor using bio-functionalized magnetized nanoparticles2009
KCNQ2-15 potassium channel2008
Pattern transfer with self-similar sacrificial mask layer and vector magnetic fi2008
Magnetic memory using single domain switching by direct current2006